86
Participants
Start Date
December 1, 2024
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
99mMaracticaltide imaging
7.3.1 99mTc-maraciclatide imaging This will be undertaken at baseline and optionally at 8-12 weeks. Not more than 75 µg of 99mTc-maraciclatide will be administered intravenously with an activity as close as possible to 740 MBq. Static whole-body imaging will be undertaken after a maximum of 2 hours with further dedicated views of the hands and feet. Total image acquisition time will be approximately 30 minutes. Images will be scored by quantitative and semi-quantitative methods by a blinded observer.
The Leeds Teaching Hospitals NHS Trust
OTHER
Serac Healthcare
UNKNOWN
Versus Arthritis
OTHER
Guy's and St Thomas' NHS Foundation Trust
OTHER